tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GB:0QAV Stock Latest News

NANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
Press ReleasesNANOBIOTIX Provides Business Update and Reports Half Year 2024 Financial Results
1d ago
NBTX
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
PremiumPress Releases
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
15d ago
NBTX
Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
PremiumPress Releases
Nanobiotix to Present at H.C. Wainwright 26th Annual Global Investment Conference
16d ago
NBTX
Nanobiotix initiated with a Buy at Guggenheim
PremiumThe Fly
Nanobiotix initiated with a Buy at Guggenheim
23d ago
NBTX
Nanobiotix initiated with a Buy at Guggenheim
PremiumThe Fly
Nanobiotix initiated with a Buy at Guggenheim
23d ago
NBTX
Voting Rights and Shares Capital of the Company
PremiumPress ReleasesVoting Rights and Shares Capital of the Company
1M ago
NBTX
Voting Rights and Shares Capital of the Company
Premium
Press Releases
Voting Rights and Shares Capital of the Company
2M ago
NBTX
Nanobiotix initiated with a Buy at Stifel
Premium
The Fly
Nanobiotix initiated with a Buy at Stifel
3M ago
NBTX
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
PremiumPress Releases
NANOBIOTIX to Host Virtual KOL Event Discussing Potential of NBTXR3 Combined With Immunotherapy in Head and Neck Cancer and Beyond on June 18, 2024
3M ago
NBTX
Voting Rights and Shares Capital of the Company
PremiumPress Releases
Voting Rights and Shares Capital of the Company
3M ago
NBTX
Nanobiotix announces new data from Study 1100
PremiumThe Fly
Nanobiotix announces new data from Study 1100
4M ago
NBTX
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
PremiumPress Releases
Nanobiotix Announces New Data Showing Disease Control and Tumor Response in Patients Treated With RT-Activated NBTXR3 Followed By anti-PD-1 For 2l+ R/M HNSCC Naïve or Resistant to Prior anti-PD-1 Therapy
4M ago
NBTX
NANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
PremiumPress ReleasesNANOBIOTIX Announces Presentation of new Data From Phase 1 Immunotherapy Program at the 2024 Annual Meeting of the American Society for Clinical Oncology Followed by an Investor Conference Call
4M ago
NBTX
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
Premium
Press Releases
NANOBIOTIX to Present at the Jefferies Global Healthcare Conference
4M ago
NBTX
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
Premium
Press Releases
NANOBIOTIX Provides First Quarter 2024 Operational and Financial Update
4M ago
NBTX
Nanobiotix provides update on NBTXR3 collaboration
PremiumThe Fly
Nanobiotix provides update on NBTXR3 collaboration
4M ago
JNJ
NBTX
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
PremiumPress Releases
Nanobiotix Announces Progress in Global NBTXR3 Development Collaboration Highlighting Robust Pipeline and Pathway to Long-Term Growth
4M ago
NBTX
Voting Rights and Shares Capital of the Company
PremiumPress Releases
Voting Rights and Shares Capital of the Company
4M ago
NBTX
NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
PremiumPress Releases
NANOBIOTIX to Announce First Quarter Operational and Financial Update on May 22, 2024
4M ago
NBTX
Nanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study
PremiumThe FlyNanobiotix announces FDA issuance of Study May Proceed Letter for NBTXR3 study
4M ago
JNJ
NBTX
NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
Premium
Press Releases
NANOBIOTIX Announces US FDA Protocol Acceptance for New Randomized Phase 2 Study Evaluating NBTXR3 for Patients with Stage Three Lung Cancer
4M ago
NBTX
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
Premium
Press Releases
NANOBIOTIX Provides Business Update and Reports Full Year 2023 Financial Results
5M ago
NBTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >